Pg 66 | Cover Story
The Reality Check: Why ESG in Pharma Must Now Prove its Value
Pg 66 | Cover Story
The Reality Check: Why ESG in Pharma Must Now Prove its Value
Beyond CSR- ESG Moves Into Boardrooms
FEATURING
- Cover Story: ESG in Pharma.
- In Talks with Leadership: Featuring Mr. Abhay Kumar Srivastava
- Market Insights: Packaging transformation & AI-led drug repurposing.
- Startup & Innovation: How GenepoweRx is transforming the genomic landscape.
- Manufacturing: Biocatalysis, automation, digital labs, and smart pharma operations.
Section Overview
Cover Story
new auth
s simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since 1966, when designers at Letraset and James Mosley, the librarian at St Bride Printing Library in London, took a 1914 Cicero translation and scrambled it to make
MAGAZINE ARTICLE by New auth+contributor
The Reality Check: Why ESG in Pharma Must Now Prove its Value
A strategic look at how ESG reporting is reshaping pharma leadership, governance, and regulatory credibility worldwide.
MAGAZINE ARTICLE by Mrudula Kulkarni
Ad
Subscribe to our Newsletter!
Be the first to get exclusive offers and the latest news